Form 4: Vicarious Surgical Director Granted Stock Options

Ahmad Fuad, a Director and 10% owner of Vicarious Surgical Inc., was granted 8,003 stock options with an exercise price of $7.61.

Summary

• Ahmad Fuad, a Director and 10% owner of Vicarious Surgical Inc. (RBOT), was granted 8,003 stock options.
• The stock options have an exercise price of $7.61 per share.
• The grant date for these options was June 27, 2025.
• All 8,003 shares underlying the option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier.
• Vesting is contingent upon Ahmad Fuad's continued service through the applicable vesting date.
• The options expire on June 26, 2035.
• Following this transaction, Ahmad Fuad beneficially owns 8,003 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The grant of stock options to a director and 10% owner is generally a positive signal, indicating alignment of interests and confidence in future performance. It's a routine compensation event, not indicative of major positive or negative news beyond that.

Positives

• Granting of stock options to a director and 10% owner aligns their interests with long-term shareholder value.
• The vesting schedule encourages continued service and commitment from a key insider.

Risks

• Vesting of options is subject to the reporting person's continued service, meaning the options could be forfeited if service ceases before the vesting date.
• The value of the options is dependent on the future stock price of Vicarious Surgical Inc. exceeding the exercise price of $7.61.

Future Outlook

The grant of stock options with a future vesting date indicates an expectation of continued service from the director and aligns their incentives with the company's long-term performance.

Industry Context

This is a standard insider transaction filing (Form 4) reporting the grant of stock options to a director. Such grants are common practice in the technology and medical device industries, including robotic surgery, to incentivize key personnel and align their interests with shareholder value. It reflects a typical compensation structure for board members.

Comparison to Industry Standards

• Granting stock options to directors is a common compensation practice across various industries, including medical technology and robotics, similar to companies like Intuitive Surgical or Stryker.
• The vesting schedule tied to continued service is standard for equity compensation, ensuring retention and alignment of interests.
• The exercise price of $7.61 would typically be the fair market value of the stock on the grant date, which is a standard practice for incentive stock options.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially encouraging decisions that enhance long-term stock value. Dilution from option exercise is a future possibility, but this is standard.

Next Steps

• The options will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier.
• The reporting person must continue service through the vesting date to receive the shares.
• The options can be exercised at any time after vesting until the expiration date of June 26, 2035.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of stock options to a director and 10% owner as part of their compensation. While it indicates alignment of interests, it does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. It's a standard insider transaction that doesn't significantly alter the investment thesis.

Keywords

Vicarious Surgical Inc., RBOT, Stock Options, Form 4, Insider Trading, Director Compensation, Equity Grant, Ahmad Fuad